Mediclinic International PLC (MDC) Given Average Recommendation of “Hold” by Analysts
Shares of Mediclinic International PLC (LON:MDC) have been assigned a consensus rating of “Hold” from the nine research firms that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell recommendation and seven have issued a hold recommendation on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is GBX 710.38 ($9.37).
MDC has been the topic of several recent analyst reports. Citigroup Inc. reiterated a “neutral” rating and issued a GBX 790 ($10.42) target price on shares of Mediclinic International PLC in a research note on Tuesday, June 27th. J P Morgan Chase & Co cut shares of Mediclinic International PLC to a “neutral” rating and lowered their target price for the stock from GBX 898 ($11.85) to GBX 733 ($9.67) in a research note on Thursday. Jefferies Group LLC lowered their target price on shares of Mediclinic International PLC from GBX 650 ($8.58) to GBX 550 ($7.26) and set an “underperform” rating on the stock in a research note on Monday, September 25th. Credit Suisse Group reiterated a “neutral” rating on shares of Mediclinic International PLC in a research note on Friday, July 21st. Finally, Morgan Stanley cut shares of Mediclinic International PLC to an “equal weight” rating and lowered their target price for the stock from GBX 825 ($10.89) to GBX 775 ($10.23) in a research note on Thursday, June 29th.
Shares of Mediclinic International PLC (LON MDC) traded down 2.65% on Wednesday, reaching GBX 623.50. 2,335,795 shares of the company were exchanged. Mediclinic International PLC has a 12-month low of GBX 620.50 and a 12-month high of GBX 941.50. The firm has a 50 day moving average price of GBX 684.15 and a 200-day moving average price of GBX 747.01. The stock’s market capitalization is GBX 4.60 billion.
About Mediclinic International PLC
Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.
Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.